EUVIMEDEUVIMED entdecken
Crossref

Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis

Allan Arnold Evans iD, Carlos Henrique Alves Jesus, Lucas Latchuk Martins, Alisson Hideki Fukuyama, Alexia Thamara Gasparin, José Alexandre Crippa iD, Antonio Waldo Zuardi, Jaime Eduardo Cecílio Hallak, Karina Genaro, Célio José de Castro Junior iD, Janaina Menezes Zanoveli, Joice Maria da Cunha iD

Cannabis and Cannabinoid Research · 2024

DOI: 10.1089/can.2021.0242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Allan Arnold Evans und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Tramadol, Diabetic Neuropathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic neuropathies are the most prevalent chronic complications of diabetes, characterized by pain and substantial morbidity. Although many drugs have been approved for the treatment of this type of pain, including gabapentin, tramadol (TMD), and classical opioids, it is common to report short-term results or potentially severe side effects. TMD, recommended as a second-line treatment can lead to unwanted side effects. Cannabidiol (CBD) has been gaining attention recently due to its therapeutic properties, including pain management. This study aimed to characterize the pharmacological interaction between CBD and TMD over the mechanical allodynia associated with experimental diabetes using isobolographic analysis. Materials and Methods: After diabetes induction by streptozotocin (STZ), diabetic rats were systemically treated with CBD or TMD alone or in combination (doses calculated based on linear regression of effective dose 40% [ED40]) and had the mechanical threshold evaluated using the electronic Von Frey apparatus. Both experimental and theoretical additive ED40 values (Zmix and Zadd, respectively) were determined for the combination of CBD plus TMD in this model.

Results

Acute treatment with CBD (3 or 10 mg/kg) or TMD (2.5, 5, 10, or 20 mg/kg) alone or in combination (0.38+1.65 or 1.14+4.95 mg/kg) significantly improved the mechanical allodynia in STZ-diabetic rats. Isobolographic analysis revealed that experimental ED40 of the combination (Zmix) was 1.9 mg/kg (95% confidence interval [CI]=1.2-2.9) and did not differ from the theoretical additive ED40 2.0 mg/kg (95% CI=1.5-2.8; Zadd), suggesting an additive antinociceptive effect in this model.

Conclusions

Using an isobolographic analysis, these results provide evidence of additive pharmacological interaction between CBD and TMD over the neuropathic pain associated with experimental diabetes induced by STZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolTramadolDiabetic NeuropathiesDiabetes Mellitus, ExperimentalAnimalsMaleRatsDrug InteractionsAnalgesics, OpioidHyperalgesiaRats, Sprague-DawleyNeuralgiaAnalgesicsDrug Therapy, Combination

Stichwörter der Autor:innen

diabetesisobologrammechanical allodynianeuropathic painpharmacological interactionstreptozotocin

Substanzen

CannabidiolTramadolAnalgesics, OpioidAnalgesics

Autor:innen und Institutionen

  • Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil.
  • National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, São Paulo, Brazil.
  • Department of Neuroscience and Behavior, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil.
  • Department of Anesthesiology, University of California, Irvine, California, USA.
  • Institute of Education and Research Santa Casa, Belo Horizonte, Minas Gerais, Brazil.

ORCID-Profile: Allan Arnold Evans, José Alexandre Crippa, Célio José de Castro Junior, Joice Maria da Cunha

Zitieren

APA

Evans, A. A., Jesus, C. H. A., Martins, L. L., Fukuyama, A. H., Gasparin, A. T., Crippa, J. A., Zuardi, A. W., Hallak, J. E. C., Genaro, K., de Castro Junior, C. J., Zanoveli, J. M., & Cunha, J. M. D. (2024). Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2021.0242

Vancouver

Evans AA, Jesus CHA, Martins LL, Fukuyama AH, Gasparin AT, Crippa JA, et al. Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2021.0242

BibTeX
@article{Evans2024,
  author = {Evans, Allan Arnold and Jesus, Carlos Henrique Alves and Martins, Lucas Latchuk and Fukuyama, Alisson Hideki and Gasparin, Alexia Thamara and Crippa, José Alexandre and Zuardi, Antonio Waldo and Hallak, Jaime Eduardo Cecílio and Genaro, Karina and de Castro Junior, Célio José and Zanoveli, Janaina Menezes and Cunha, Joice Maria da},
  title = {Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis},
  journal = {Cannabis and Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2021.0242}
}
Kostenlos starten →